IIM
INDV icon

INTECH Investment Management’s Indivior Pharmaceuticals INDV Stock Holding History

INTECH Investment Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Buy
107,818
+18,873
+21% +$685K 0.04% 406
2026
Q1 		$2.71M Buy
88,945
+37,997
+75% +$1.25M 0.03% 570
2025
Q4 		$1.83M Buy
50,948
+9,773
+24% +$298K 0.02% 785
2025
Q3 		$993K Sell
41,175
-20,478
-33% -$429K 0.01% 1167
2025
Q2 		$909K Buy
+61,653
New +$718K 0.01% 1260

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's INDV Position: Q2 2026 in Review

INTECH Investment Management increased its Indivior Pharmaceuticals (INDV) stake by 21% in Q2 2026, buying an estimated $685K and bringing the position to 107,818 shares worth $4.42M. The position accounts for 0.04% of the portfolio, ranked #406.

INTECH Investment Management first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • INTECH Investment Management held 107,818 shares of Indivior Pharmaceuticals worth $4.42M as of Q2 2026.
  • INTECH Investment Management bought 18,873 Indivior Pharmaceuticals shares in Q2 2026, an estimated $685K.
  • Indivior Pharmaceuticals made up 0.04% of INTECH Investment Management's portfolio in Q2 2026, its #406 holding.
  • INTECH Investment Management first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.